 World News
 USA (197)
 Bay Area
 Business (1003)
 Bio Tech (90)
Peninsula
 2007 (5)
2006 (6)
2005 (2)
2004 (2)
2003 (2)
2002 (1)
Central San Mateo County
Hayward Castro Valley San Leandro
Richest Towns
South San Mateo County
SFO
Redwood City
San Mateo
 Peninsula on Wikipedia
 Peninsula on Web
 Peninsula Books
 Real Estate
|
|
|
| Aug. 27 |
South SF |
Cell Genesys Drug Trial Halts| Shares plunged more than 70% after a clinical trial of its cancer vaccine Gvax was stopped due to a higher number of deaths among patients | |
|
| Aug. 21 |
Genentech |
Retention plan to cost $371 million An employee retention plan announced along with its rejection of Roche's buyout offer will cost the biotechnology giant about $371 million
|
| Aug. 17 |
Genentech |
Recruiters eye Genentech employees While Roche mulls whether to raise its offer price for biotechnology powerhouse, many prized Genentech professionals
|
| Aug. 13 |
Genentech |
Genentech rejects Roche's $43.7b bid| Biotechnology giant rejected a buyout offer from its majority owner Roche but said it is open to a higher takeover bid | | |
|
|
| Jul.31 |
Genentech |
Shareholders sue to halt Roche buyout Shareholders' attorneys are asking a court to invalidate long-standing agreements between Genentech and its majority owner
|
| Jul.25 |
Genentech |
Panel to ponder Roche takeover offer Genentech has set up a committee of independent directors to consider Swiss drugmaker offer to acquire all shares it does not already own
|
| Jul.21 |
Genentech |
Roche Offers $44B For Remaining Shares| Roche Holding, which already owns 55.9%, was offering $43.7 billion to take over the remaining shares of Genentech | |
|
|
| Jun.12 |
Foster City |
Invitrogen to buy Applied Biosystems| Invitrogen agreed to pay $6.4 billion in cash and stock for scientific instruments maker Applera's Applied Biosystems Group | |
|
|
| Apr.30 |
Genentech |
Bad news on cancer drug Rituxan Shares in Genentech sagged, after the company said Rituxan failed to curb symptoms of the debilitating autoimmune disorder
|
| Apr.24 |
Genentech |
Court slashes $200 million from judgment The company has been ordered to pay $500 million to a Southern California hospital for failing to pay royalties
|
|
| |
Bay Area Nurses Launch 10-Day Strike
|
|
| Feb.22 |
Genentech |
FDA Clears Avastin for Breast Cancer| A Genentech drug received federal approval, a surprise decision | |
|
| Feb.17 |
South SF |
Prostate cancer vaccine shows promise Shares in Cell Genesys shot up nearly 20% after the company released a favorable analysis of its experimental prostate cancer vaccine GVAX
|
|
| |
Rogue trader to cost SocGen $7bn
|
| Jan.14 |
Genentech |
4Q Profit Rises 6 Percent The biotech giant barely scraped past expectations as stock dropped in after-hours trading as sales of a key product also fell below expecta...
|
|
| Dec.5 |
Genentech |
FDA Panel Rejects Avastin, stock drops Shares dropped nearly 9% after a panel of medical experts said FDA should deny approval of the company's blockbuster drug
|
| Oct.16 |
Genentech |
3Q Profit Up 21 % On Cancer Drug Sales The profit rose nearly 21% from a year ago, beating expectations by a penny thanks to stronger-than-expected sales of the Avastin
|
| Aug.3 |
Genentech |
Genentech completes Tanox acquisition
|
| |
Ex-execs in SEC sights
|
| Mar.24 |
Genentech |
Genentech projects quarter to be 'flat'
|
|
| Dec.21 |
Genentech |
Genentech gets rights to drug
|
| Nov.11 |
Genentech |
Genentech to acquire partner Tanox Genentech Inc. has agreed to its first acquisition ever - Tanox Inc., co-developer of the asthma medicine Xolair
|
| Sep.12 |
Genentech |
Avastin approval slowed by FDA
|
| Aug.12 |
Genentech |
Cancer drug review extended
|
| Jul.31 |
Genentech |
Tony Blair Visits Genentech Headquarters Heavy hitters from biotech firms sat down for an extraordinary talk with British Prime Minister
|
| Feb.13 |
Genentech |
Cancer Drug Trials Scaled Back Avastin only targets cancer, and leaves healthy cells alone
|
|
| |
Novartis to buy Chiron
|
| Jul.11 |
Genentech |
Profits Soar 73% in 2Q The second quarter profit is fueled by continued strong drug sales. The results exceeded the estimate by 4 cents
|
|
| Nov.4 |
Brisbane |
VaxGen gets contract for anthrax vaccine The government is purchasing 75 million doses of a new generation vaccine under an $877.5 million
|
| |
Flu maker Chiron slashes profit outlook
|
|
| May.19 |
Genentech |
Encouraging results with cancer drug Avastin extended the lives of some of the colon cancer patients. Company's stock soaring nearly 45%
|
| Feb.23 |
Brisbane |
AIDS vaccine developed by VaxGen An experimental vaccine does not protect most people, but showed promise in protecting blacks and Asians
|
|
| Sep.7 |
Genentech |
Big patent win vs. Chiron Chiron of Emeryville has no claim to any profits from Genentech's blockbuster breast cancer drug, Herceptin
Add a favorite (file a bookmark) to Peninsula, Bio Tech Timeline
Please send feedback to: support@mapreport.com
Advertise on Peninsula, Bio Tech Page
To sell or purchase a home in the Peninsula complete this form
|
